期刊文献+

高效液相质谱联用法测定人血清中多奈哌齐和卡巴拉汀药物浓度 被引量:1

Determination of Donepezil and Rivastigmine in Human Serum by High-performance Liquid Chromatography Combined with Mass Spectrum
下载PDF
导出
摘要 目的:建立测定人血清中多奈哌齐和卡巴拉汀浓度的方法。方法:200μl血清样本采用600μl乙腈沉淀蛋白,离心取上清后,采用HPLC-MS/MS测定,以氯雷他定为内标,色谱柱为Waters Xselect CSH C_(18)(150 mm×3 mm,2. 5μm),流动相为水(含10 mmol·L^(-1)乙酸铵)-乙腈(20∶80),流速0. 4 ml·min^(-1),柱温40℃,进样量10μl,采用电喷雾离子源,以多反应监测方式进行正离子扫描,以[M+H]+作为分子离子峰,用于多奈哌齐和卡巴拉汀定量的反应离子对分别为m/z 380. 1→m/z91. 1和m/z 251→m/z 206. 5,用于内标定量的反应离子对为m/z 383. 1→m/z 337. 1。结果:两种药物在0. 5~400 ng·ml^(-1)范围内线性关系良好(r> 0. 99),定量下限均为0. 5 ng·ml^(-1);多奈哌齐的日内、日间精密度为2. 06%~12. 51%,相对偏差(RE)为-6. 60%~4. 20%,提取回收率为80. 76%~96. 17%,RSD <15%。卡巴拉汀的日内、日间精密度为1. 69%~9. 31%,RE为-5. 58%~5. 20%,提取回收率为96. 69%~100. 15%,RSD <15%。多奈哌齐和卡巴拉汀血清样品在经历3次冻融(-40℃到室温)循环、-40℃放置75 d条件下均稳定,处理后样品在自动进样器中(4℃)放置5 h均稳定(RSD <15%)。结论:该方法快速、准确、灵敏度高、专属性强,可应用于血药浓度测定和人体药物动力学研究。 Objective: To develop an LC-M/S method for the determination of donepezil and rivastigmine in human serum.Methods: After protein precipitation with 600μl acetonitrile,the serum samples were analyzed by LC-M/S. Using loratadine as the internal standard,a Waters Xselect CSH C_(18)( 150 mm × 3 mm,2. 5 μm) column was used with the mobile phase consisting of water( containing 10 mmol·L^-1 ammonium acetate)-acetonitrile( 20 ∶ 80) at a flow rate of 0. 4 ml·min^-1 with the column temperature at 40 ℃. The ion transitions were performed in a positive electrospray ionization multiple reaction-monitoring mode regarding [M + H]+as the molecular ion peak of donepezil and rivastigmine monitored with / 380. 1→/ 91. 1 and / 251→/ 206. 5,respectively.The internal standard was monitored with / 383. 1→/ 337. 1. Results: The linear range of donepezil and rivastigmine was 0. 5-400 ng·ml^-1( r〉0. 99) and the lowest quantification limit was 0. 5 ng·ml^-1. For donepezil,the intra-day and inter-day RSD was2. 06% to 12. 51%,the relative error was-6. 60% to 4. 20%,and the relative recovery was ranged from 80. 76% to 96. 17%( RSD〈15%). For rivastigmine,the intra-day and inter-day RSD was 1. 69% to 9. 31%,the relative error was-5. 58% to 5. 20%,and the mean relative recovery was ranged from 96. 69% to 100. 15%( RSD 15%). For the two compounds,the serum samples were stable at-40℃ for 75 d and kept stable after three repeated freeze-thaw cycles. The prepared samples were stable in the automatic sample injector( 4℃) for 5 h( RSD〈15%). Conclusion: The developed assay method can be applied in the therapeutic monitoring and pharmacokinetic study of donepezil and rivastigmine in human serum.
作者 苏甦 沈芊 王彦改 王雪梅 魏翠柏 闫素英 Su Su;Shen Qian;Wang Yangai;Wang Xuemei;Wei Cuibai;Yan Suying(Pharmacy Department;Neurology De-partment;Xuanwu Hospital,Capital Medical University,Beijing 100053,China;3.National Clinical Research Center for Geriatric Disorder)
出处 《中国药师》 CAS 2018年第10期1725-1731,共7页 China Pharmacist
基金 北京市卫生和计划生育委员会"老年重大疾病关键技术研究"课题(编号:PXM2017_026283_000002) 北京市科学技术委员会"北京老年人健康评估及维护关键技术研究"专项资助课题(编号:D181100000218002) 十三五国家重点研发计划慢病专项课题(编号:2017YFC1310103) 北京市医院管理局临床医学发展专项(编号:ZYLX201837)
关键词 多奈哌齐 卡巴拉汀 高效液相质谱联用法 方法学评价 人血清药物浓度 Donepezil Rivastigmine HPLC-MS/MS Method validation Human serum drug concentration
  • 相关文献

参考文献6

二级参考文献63

共引文献302

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部